APO RESEARCH · REPORT
General Anesthesia Drugs
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
Product & engineering
Understand the product.
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
Selected research
Industry Research
General Anesthesia Drugs Industry Research Report 2026
Market perspective
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
The major players in global General Anesthesia Drugs market include Astrazeneca, Fresenius-Kabi, B.Braun, etc. The top 3 players occupy about 40% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Propofol is the main type, with a share about 30%. Intravenous Anesthetics is the main application, which holds a share about 70%.
Report Scope
Read the full market overview
This report quantifies the global General Anesthesia Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
General Anesthesia Drugs Market by Company
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
General Anesthesia Drugs Segment by Type
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others
General Anesthesia Drugs Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
General Anesthesia Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthesia Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of General Anesthesia Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of General Anesthesia Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of General Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Propofol
- Etomidate
- Midazolam
- Sevoflurane
- Isoflurane
- Others
Applications
- Intravenous Anesthetics
- Inhalational Anesthetics
Companies covered
- Astrazeneca
- Fresenius-Kabi
- AbbVie
- Baxter Healthcare
- B.Braun
- Maruishi
- Piramal
- Hikma Pharmaceuticals
- Mylan
- Nhwa
- Hengrui
- Lunan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global General Anesthesia Drugs Market Size (2021-2032)
- 2.2.2 Global General Anesthesia Drugs Sales (2021-2032)
- 2.2.3 Global General Anesthesia Drugs Market Average Price (2021-2032)
- 2.3 General Anesthesia Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Propofol
- 2.3.3 Etomidate
- 2.3.4 Midazolam
- 2.3.5 Sevoflurane
- 2.3.6 Isoflurane
- 2.3.7 Others
- 2.4 General Anesthesia Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Intravenous Anesthetics
- 2.4.3 Inhalational Anesthetics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global General Anesthesia Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global General Anesthesia Drugs Sales (K L) of Manufacturers (2021-2026)
- 3.3 Global General Anesthesia Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global General Anesthesia Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global General Anesthesia Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of General Anesthesia Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of General Anesthesia Drugs, Product Type & Application
- 3.8 Global Manufacturers of General Anesthesia Drugs, Established Date
- 3.9 Global General Anesthesia Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Astrazeneca
- 4.1.1 Astrazeneca Company Information
- 4.1.2 Astrazeneca Business Overview
- 4.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Astrazeneca General Anesthesia Drugs Product Portfolio
- 4.1.5 Astrazeneca Recent Developments
- 4.2 Fresenius-Kabi
- 4.2.1 Fresenius-Kabi Company Information
- 4.2.2 Fresenius-Kabi Business Overview
- 4.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fresenius-Kabi General Anesthesia Drugs Product Portfolio
- 4.2.5 Fresenius-Kabi Recent Developments
- 4.3 AbbVie
- 4.3.1 AbbVie Company Information
- 4.3.2 AbbVie Business Overview
- 4.3.3 AbbVie General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 AbbVie General Anesthesia Drugs Product Portfolio
- 4.3.5 AbbVie Recent Developments
- 4.4 Baxter Healthcare
- 4.4.1 Baxter Healthcare Company Information
- 4.4.2 Baxter Healthcare Business Overview
- 4.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Baxter Healthcare General Anesthesia Drugs Product Portfolio
- 4.4.5 Baxter Healthcare Recent Developments
- 4.5 B.Braun
- 4.5.1 B.Braun Company Information
- 4.5.2 B.Braun Business Overview
- 4.5.3 B.Braun General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 B.Braun General Anesthesia Drugs Product Portfolio
- 4.5.5 B.Braun Recent Developments
- 4.6 Maruishi
- 4.6.1 Maruishi Company Information
- 4.6.2 Maruishi Business Overview
- 4.6.3 Maruishi General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Maruishi General Anesthesia Drugs Product Portfolio
- 4.6.5 Maruishi Recent Developments
- 4.7 Piramal
- 4.7.1 Piramal Company Information
- 4.7.2 Piramal Business Overview
- 4.7.3 Piramal General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Piramal General Anesthesia Drugs Product Portfolio
- 4.7.5 Piramal Recent Developments
- 4.8 Hikma Pharmaceuticals
- 4.8.1 Hikma Pharmaceuticals Company Information
- 4.8.2 Hikma Pharmaceuticals Business Overview
- 4.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolio
- 4.8.5 Hikma Pharmaceuticals Recent Developments
- 4.9 Mylan
- 4.9.1 Mylan Company Information
- 4.9.2 Mylan Business Overview
- 4.9.3 Mylan General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mylan General Anesthesia Drugs Product Portfolio
- 4.9.5 Mylan Recent Developments
- 4.10 Nhwa
- 4.10.1 Nhwa Company Information
- 4.10.2 Nhwa Business Overview
- 4.10.3 Nhwa General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nhwa General Anesthesia Drugs Product Portfolio
- 4.10.5 Nhwa Recent Developments
- 4.11 Hengrui
- 4.11.1 Hengrui Company Information
- 4.11.2 Hengrui Business Overview
- 4.11.3 Hengrui General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hengrui General Anesthesia Drugs Product Portfolio
- 4.11.5 Hengrui Recent Developments
- 4.12 Lunan
- 4.12.1 Lunan Company Information
- 4.12.2 Lunan Business Overview
- 4.12.3 Lunan General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Lunan General Anesthesia Drugs Product Portfolio
- 4.12.5 Lunan Recent Developments
5 Global General Anesthesia Drugs Market Scenario by Region
- 5.1 Global General Anesthesia Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global General Anesthesia Drugs Sales by Region: 2021-2032
- 5.2.1 Global General Anesthesia Drugs Sales by Region: 2021-2026
- 5.2.2 Global General Anesthesia Drugs Sales by Region: 2027-2032
- 5.3 Global General Anesthesia Drugs Revenue by Region: 2021-2032
- 5.3.1 Global General Anesthesia Drugs Revenue by Region: 2021-2026
- 5.3.2 Global General Anesthesia Drugs Revenue by Region: 2027-2032
- 5.4 North America General Anesthesia Drugs Market Facts & Figures by Country
- 5.4.1 North America General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America General Anesthesia Drugs Sales by Country (2021-2032)
- 5.4.3 North America General Anesthesia Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe General Anesthesia Drugs Market Facts & Figures by Country
- 5.5.1 Europe General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe General Anesthesia Drugs Sales by Country (2021-2032)
- 5.5.3 Europe General Anesthesia Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific General Anesthesia Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific General Anesthesia Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific General Anesthesia Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America General Anesthesia Drugs Market Facts & Figures by Country
- 5.7.1 South America General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America General Anesthesia Drugs Sales by Country (2021-2032)
- 5.7.3 South America General Anesthesia Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa General Anesthesia Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa General Anesthesia Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa General Anesthesia Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global General Anesthesia Drugs Sales by Type (2021-2032)
- 6.1.1 Global General Anesthesia Drugs Sales by Type (2021-2032) & (K L)
- 6.1.2 Global General Anesthesia Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global General Anesthesia Drugs Revenue by Type (2021-2032)
- 6.2.1 Global General Anesthesia Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global General Anesthesia Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global General Anesthesia Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global General Anesthesia Drugs Sales by Application (2021-2032)
- 7.1.1 Global General Anesthesia Drugs Sales by Application (2021-2032) & (K L)
- 7.1.2 Global General Anesthesia Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global General Anesthesia Drugs Revenue by Application (2021-2032)
- 7.2.1 Global General Anesthesia Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global General Anesthesia Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global General Anesthesia Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 General Anesthesia Drugs Value Chain Analysis
- 8.1.1 General Anesthesia Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 General Anesthesia Drugs Production Mode & Process
- 8.2 General Anesthesia Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 General Anesthesia Drugs Distributors
- 8.2.3 General Anesthesia Drugs Customers
9 Global General Anesthesia Drugs Analyzing Market Dynamics
- 9.1 General Anesthesia Drugs Industry Trends
- 9.2 General Anesthesia Drugs Industry Drivers
- 9.3 General Anesthesia Drugs Industry Opportunities and Challenges
- 9.4 General Anesthesia Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst